Back to Search
Start Over
POINT–COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations—no definite conclusions.
- Source :
- International Journal of Hyperthermia; Jan/Feb2002, Vol. 18 Issue 1, p19-24, 6p, 1 Chart
- Publication Year :
- 2002
-
Abstract
- Randomized trials have shown that results of radiotherapy in patients with cervical cancer can be improved by combining the treatment with either cisplatin based chemotherapy, or hyperthermia. The studies on both the combination of radiotherapy with chemotherapy, and the combination on radiotherapy with hyperthermia, leave several important questions unanswered. At present, no definite conclusions can be drawn with regard to which combination results in the best therapeutic ratio. Therefore, on both ethical and scientific grounds, the next logical step would be to compare the two types of combined treatment to each other, and each combination with a treatment including all three modalities, in a randomized fashion. [ABSTRACT FROM AUTHOR]
- Subjects :
- THERMOTHERAPY
CISPLATIN
RADIOTHERAPY
CANCER treatment
Subjects
Details
- Language :
- English
- ISSN :
- 02656736
- Volume :
- 18
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- International Journal of Hyperthermia
- Publication Type :
- Academic Journal
- Accession number :
- 5877685
- Full Text :
- https://doi.org/10.1080/02656730110083738